Harnessing ferroptosis to transform glioblastoma therapy and surmount treatment resistance | Cell Death Discovery

Nature·Oct 7

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Research is exploring the potential of ferroptosis to improve glioblastoma therapy and overcome treatment resistance. Studies are investigating the mechanisms of ferroptosis in glioblastoma, including its relationship to metabolic reprogramming, immune evasion, and antioxidant defense. The role of various factors, such as TP63 and dopamine, in modulating ferroptosis in glioblastoma is also being examined.

Full coverage

Ferroptosis and metabolic reprogramming in the immunosuppressive microenvironment of glioblastoma: emerging mechanisms and novel strategies

Frontiers·Mar 9

Ioning out glioblastoma: ferroptosis mechanisms and therapeutic frontiers

Nature·Aug 26

Metabolic remodeling and immune evasion in glioblastoma: a focus on serine and lipid networks

Frontiers·Feb 2

TP63 as a modulator of ferroptosis in TP53 mutations glioblastoma - Cell Death & Disease

Nature·Aug 13

Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosis

Nature·Sep 5

Iron commensalism of mesenchymal glioblastoma promotes ferroptosis susceptibility upon dopamine treatment

Nature·Jun 16

View original report at Nature ↗

Fetching the latest headlines…